BBOT granted US FDA fast track designation for BBO-11818 for treatment of adult patients with advanced KRAS-mutant pancreatic ductal adenocarcinoma

Published: 2026-04-20 17:59:32 ET BBOT

Published on 04/20/2026 at 05:59 pm EDT